LUPUS ERYTHEMATOSUS, SYSTEMIC
Clinical trials for LUPUS ERYTHEMATOSUS, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS, SYSTEMIC trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn lupus: drug targets fever and inflammation
Disease control Not yet recruitingThis small pilot study tests a drug called firsekibart in 15 adults with mild-to-moderate lupus who did not get better with usual therapies. The drug blocks a protein (IL-1) that causes fever and inflammation. The main goal is to see if lupus symptoms improve after 12 weeks of tr…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Fish oil fights lupus inflammation in new trial
Disease control Not yet recruitingThis study tests whether taking high-dose omega-3 (fish oil) pills for 12 weeks can reduce inflammation and cell damage in women with lupus who have mild disease. Eighty women aged 18-45 will receive either omega-3 or a placebo. Researchers will measure changes in blood markers o…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Hypnotherapy may replace pills for Needle-Phobic kids
Symptom relief Not yet recruitingThis study tests whether hypnotherapy can reduce pain and anxiety in children aged 6 to 18 during needle procedures like injections or blood draws. About 70 kids will be randomly assigned to receive either hypnotherapy sessions or standard care. The goal is to find a safe, drug-f…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC